BridgeBio
Palo Alto, CA
BridgeBio Pharma, Inc. operates as a pharmaceutical company. The Company discovers and develops drugs for patients with grievous genetic diseases. BridgeBio Pharma offers medicines for different medical areas such as cardiology, neurology, oncology, and dermatology. BridgeBio Pharma serves patients in the State of California.
bridgebio.comCompany Details
Founded
- 2014
Employees
- 730 employees
Raised
- $4,349,199,360
Headquarters Location
- Palo Alto, CA
Public
- Yes
Acquired
- No
CEO
Neil Kumar
Founders
- Frank McCormickCharles HomcyNeil Kumar
Company Collections
These are collections BridgeBio is a part of. Click on the collection name to view similar companies.
BridgeBio's Investors
BridgeBio's Industries
Current Job Listings
BridgeBio Headquarters Location
Total Amount Raised: $4,349,199,360
BridgeBio's Investors
BridgeBio Funding Rounds
Post Ipo Debt
$500,000,000
Post Ipo Equity
$250,000,000
Post Ipo Debt
$1,250,000,000
Post Ipo Debt Investors
Blue OwlCPP Investment BoardPost Ipo Equity
$250,000,000
Post Ipo Equity Investors
Qatar Investment AuthorityPost Ipo Equity
$150,000,000
Post Ipo Debt
$750,000,000
Post Ipo Debt
$250,000,000
Post Ipo Debt
$475,000,000
Series D
$299,200,000
Series D Investors
KKRViking Global InvestorsHercules CapitalAisling CapitalCormorant CapitalAIG InvestmentsSequoia CapitalPerceptive AdvisorsIPO
Unknown
Series C
$135,000,000
Series C Investors
KKRViking Global InvestorsPerceptive AdvisorsAIG InvestmentsAisling CapitalCormorant CapitalJanus FundSeries B
$33,100,000
Series B Investors
KKRSeries B
$6,900,000
Series B Investors
KKR
BridgeBio Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on BridgeBio.